MedPath

DOXORUBICIN HYDROCHLORIDE INJECTION

DOXORUBICIN HYDROCHLORIDE INJECTION

Approved
DIN Number

02409275

Drug Class

Human

Market Date

Feb 27, 2014

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02409275
AIG Number0110825002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01DB01 DOXORUBICIN
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous ,  Intravesical
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DOXORUBICIN HYDROCHLORIDEActive
Strength: 2 MG / ML
Monograph: DOXORUBICIN HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.